Veradigm Return on Investment 2010-2022 | MDRX
Veradigm ROI - Return on Investment Historical Data | |||
---|---|---|---|
Date | TTM Net Income | LT Investments & Debt | Return on Investment |
2022-12-31 | $-0.03B | $1.22B | -1.82% |
2022-09-30 | $0.06B | $1.38B | 3.93% |
2022-06-30 | $0.05B | $1.40B | 3.26% |
2022-03-31 | $0.08B | $1.73B | 4.31% |
2021-12-31 | $0.08B | $1.71B | 4.30% |
2021-09-30 | $0.11B | $1.79B | 6.26% |
2021-06-30 | $0.09B | $1.82B | 4.40% |
2021-03-31 | $0.04B | $1.85B | 2.20% |
2020-12-31 | $0.01B | $1.83B | 0.41% |
2020-09-30 | $-0.17B | $2.23B | -8.76% |
2020-06-30 | $-0.16B | $1.91B | -8.48% |
2020-03-31 | $-0.13B | $1.92B | -6.67% |
2019-12-31 | $-0.10B | $1.84B | -4.93% |
2019-09-30 | $-0.09B | $1.84B | -4.32% |
2019-06-30 | $-0.09B | $2.14B | -3.96% |
2019-03-31 | $-0.16B | $2.22B | -6.29% |
2018-12-31 | $-0.17B | $2.23B | -6.32% |
2018-09-30 | $-0.11B | $2.91B | -4.25% |
2018-06-30 | $-0.09B | $2.76B | -3.43% |
2018-03-31 | $-0.01B | $2.81B | -0.24% |
2017-12-31 | $0.01B | $2.07B | 0.50% |
2017-09-30 | $0.08B | $2.53B | 3.06% |
2017-06-30 | $0.07B | $2.48B | 2.73% |
2017-03-31 | $0.07B | $2.49B | 2.64% |
2016-12-31 | $0.07B | $2.58B | 2.82% |
2016-09-30 | $0.07B | $2.58B | 3.12% |
2016-06-30 | $0.06B | $2.52B | 2.94% |
2016-03-31 | $0.05B | $1.98B | 2.48% |
2015-12-31 | $0.03B | $2.03B | 1.62% |
2015-09-30 | $0.01B | $2.04B | 0.52% |
2015-06-30 | $-0.02B | $2.02B | -0.96% |
2015-03-31 | $-0.03B | $1.82B | -1.80% |
2014-12-31 | $-0.04B | $1.82B | -2.13% |
2014-09-30 | $-0.07B | $1.85B | -3.69% |
2014-06-30 | $-0.09B | $1.84B | -4.97% |
2014-03-31 | $-0.11B | $1.84B | -5.95% |
2013-12-31 | $-0.13B | $1.86B | -6.85% |
2013-09-30 | $-0.13B | $1.86B | -7.00% |
2013-06-30 | $-0.07B | $1.90B | -4.21% |
2013-03-31 | $-0.03B | $1.79B | -1.64% |
2012-12-31 | $0.01B | $1.65B | 0.76% |
2012-09-30 | $0.09B | $1.69B | 4.93% |
2012-06-30 | $0.11B | $1.70B | 6.29% |
2012-03-31 | $0.13B | $1.79B | 6.99% |
2011-12-31 | $0.14B | $1.80B | 7.55% |
2011-09-30 | $0.10B | $1.78B | 5.51% |
2011-06-30 | $0.07B | $1.79B | 3.54% |
2011-03-31 | $0.05B | $1.84B | 3.88% |
2010-09-30 | $0.05B | $1.88B | 11.09% |
2010-06-30 | $0.09B | 42.45% | |
2010-03-31 | $0.09B | 15.27% | |
2010-02-28 | $0.08B | $0.80B | 13.59% |
2009-09-30 | $0.07B | 11.51% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $0.449B | $0.588B |
Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Veeva Systems (VEEV) | United States | $35.134B | 48.53 |
Tempus AI (TEM) | United States | $6.966B | 0.00 |
Hims & Hers Health (HIMS) | United States | $6.050B | 97.25 |
Inspire Medical Systems (INSP) | United States | $4.470B | 86.83 |
IRhythm Technologies (IRTC) | United States | $3.223B | 0.00 |
Privia Health (PRVA) | United States | $2.873B | 215.27 |
Schrodinger (SDGR) | United States | $1.881B | 0.00 |
Clover Health Investments (CLOV) | United States | $1.839B | 0.00 |
Enovis (ENOV) | United States | $1.825B | 11.29 |
Omnicell (OMCL) | United States | $1.418B | 30.59 |
Phreesia (PHR) | United States | $1.409B | 0.00 |
Azenta (AZTA) | United States | $1.154B | 53.72 |
10x Genomics (TXG) | United States | $0.918B | 0.00 |
Butterfly Network (BFLY) | United States | $0.568B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.551B | 0.00 |
Talkspace (TALK) | United States | $0.450B | 267.00 |
Standard BioTools (LAB) | United States | $0.440B | 0.00 |
TruBridge (TBRG) | United States | $0.363B | 0.00 |
Claritev (CTEV) | United States | $0.325B | 0.00 |
Health Catalyst (HCAT) | United States | $0.270B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.206B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.189B | 0.00 |
Pulmonx (LUNG) | United States | $0.182B | 0.00 |
American Well (AMWL) | United States | $0.109B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.100B | 0.00 |
Retrieve Medical Holdings (RMHI) | United States | $0.082B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.076B | 0.00 |
P3 Health Partners (PIII) | United States | $0.066B | 0.00 |
111 (YI) | China | $0.064B | 0.00 |
CareCloud (CCLD) | United States | $0.060B | 2.58 |
HeartBeam (BEAT) | United States | $0.055B | 0.00 |
Outset Medical (OM) | United States | $0.040B | 0.00 |
Zepp Health (ZEPP) | China | $0.039B | 0.00 |
Zhongchao (ZCMD) | China | $0.030B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
MSP Recovery (MSPR) | United States | $0.014B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.010B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
Precipio (PRPO) | United States | $0.009B | 0.00 |
Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
Movano (MOVE) | United States | $0.007B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
HeartSciences (HSCS) | United States | $0.004B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
Syra Health (SYRA) | United States | $0.001B | 0.00 |
Future Health ESG (FHLT) | United States | $0.000B | 0.00 |